THE PTSD CHRONICLE – Clinical trials and research are at the heart of medical advances — from cause to cure.
The COVID vaccine provides ample evidence of the value and efficacy of trials, which look at new ways to prevent, detect and treat disease.
According to research, the success rates for PTSD range from as low as 25% to just over 60%, according to CenterWatch, a leading publisher of information on clinical research for patients, their advocates and healthcare professionals.
Because so many patients have low success with their treatment, there is a need to research and develop additional treatment options for PTSD.
Increased participation in PTSD clinical trials and research help those battling the condition know that they are not facing their disorder on their own.
Safety is always on the forefront of clinical trials, which are used to determine if a new test or treatment works and is safe. Although many associate clinical trials with new conditions, they also are used to help advance aspects of care, like improving the quality of life of people with chronic conditions.
The motivation for participating in clinical trials varies. All leave a lasting legacy.
Many healthy volunteers take part to help others and to contribute to advances in medical science.
Although participation does not guarantee an immediate impact, it contributes to the hope of medical advances impacting our children, grandchildren and generations to come.
Register for our newsletter to receive updates on clinical trial results, announcements about promising new treatments and additional news about clinical trials. And visit CenterWatch to get additional information on clinical research, as well as access its handy FDA-approved medication search tool.
Editor’s note: If you are interested in participating in clinical trials and research studies, click here.